About Dalton | Bohr
Strategic advisory for biotechnology innovators navigating intellectual property, development, financing, and commercialization.
Dalton | Bohr was founded to help life science companies bridge the gap between scientific innovation and commercial success. We work with founders, executives, investors, and research organizations to develop strategies that create durable intellectual property, attract capital, and accelerate value creation.
Our Philosophy
Most biotechnology companies do not fail because of poor science.
They fail because promising technologies are not positioned correctly for funding, development, partnering, or commercialization.
Dalton | Bohr was founded on a simple principle:
Scientific innovation creates potential. Strategic execution creates value.
We help organizations make critical decisions at the intersection of science, intellectual property, business development, and corporate strategy.
Founder
Joshua S. Schoonover, A.L.M., J.D.
Registered U.S. Patent Attorney | Biotechnology Executive | Entrepreneur
Joshua Schoonover is a biotechnology executive, entrepreneur, and registered U.S. patent attorney with experience spanning intellectual property strategy, technology licensing, oncology therapeutics, diagnostics, corporate development, financing, and biotechnology commercialization.
He currently serves as General Counsel and Vice President of Business Development for a publicly traded biotechnology company and has participated in the development, protection, financing, licensing, and advancement of multiple biotechnology platforms.
His experience spans:
- Intellectual property strategy and portfolio development
- Technology licensing and partnering
- Corporate formation and governance
- Non-dilutive funding strategy
- Translational biotechnology
- Oncology therapeutics
- Diagnostics and medical technologies
- Strategic transactions and commercialization planning
Joshua combines scientific training, legal expertise, and operating experience to provide practical guidance to organizations navigating complex life science opportunities.
What Makes Dalton | Bohr Different
Many advisors understand one aspect of biotechnology.
Few understand the full lifecycle.
Dalton | Bohr brings together expertise across:
Science
Understanding the biology, technology, and development challenges underlying innovative products.
Intellectual Property
Building patent portfolios and freedom-to-operate strategies that support long-term value creation.
Business Development
Structuring partnerships, licenses, collaborations, and strategic transactions.
Capital Formation
Positioning companies and technologies for investment, grant funding, and commercialization.
This integrated perspective allows clients to make decisions with a clear understanding of both scientific and commercial implications.
Who We Work With
Dalton | Bohr works with:
- Biotechnology startups
- Academic founders and spinouts
- Therapeutics companies
- Diagnostic companies
- Medical device innovators
- Investors evaluating life science opportunities
- Corporate development teams
- Research institutions and technology transfer organizations
Areas of Engagement
Common engagements include:
- Intellectual property strategy
- Patent portfolio development
- Technology assessments
- Licensing and partnering transactions
- Scientific and commercial diligence
- Grant strategy and non-dilutive funding
- Corporate formation and governance
- Strategic planning for emerging biotechnology companies
Our Approach
Every engagement is guided by three principles:
Discretion
Sensitive scientific, intellectual property, and business matters are handled with professionalism and confidentiality.
Precision
Recommendations are grounded in scientific, legal, and commercial realities.
Execution
Advice must translate into action. We focus on practical strategies that move organizations forward.
Let’s Start a Conversation
Whether you are evaluating a new technology, preparing for investment, building an intellectual property strategy, or pursuing a strategic transaction, Dalton | Bohr provides experienced guidance at the intersection of biotechnology, intellectual property, and capital.
Contact Dalton | Bohr